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MANAGEMENT OUTCOME OF RESIDUAL COMMON BILE DUCT 
STONES AT AGA KHAN UNIVERSITY HOSPITAL 
Muhammad Rizwan Khan, Sameera Naureen, Dildar Hussain, Rizwan Azami 
Department of Surgery, The Aga Khan University Hospital, Karachi. 
Background: The frequency of residual common bile duct (CBD) stones in patients with previous 
cholecystectomy ranges from 2-10%, and a minimally invasive approach is generally 
recommended for these patients. This study reviews the experience in the management of residual 
CBD stones at the Aga Khan University Hospital. Methods: All adult patients diagnosed to have 
residual CBD stones, from 1993 to 2001, were identified and analyzed in terms of the treatment 
modality utilized and its associated complications. The role of endoscopic sphincterotomy was 
particularly analyzed in our set-up. Results: The study population consisted of 66 patients. The 
mean age was 52 (range:18-84 years) years with a female to male ratio of 51:15. The primary 
mode of management consisted of endoscopic sphincterotomy in 61 patients (92.5%). The initial 
clearance rate for these patients was 75%, while the remaining 25% required ancillary procedures 
to achieve a complete clearance. Procedure related complications were observed in 17 (28%) 
patients, with zero mortality. The other 5 patients (7.5%) underwent an open choledochotomy as a 
primary procedure with no further complications. Conclusions: Endoscopic sphincterotomy is the 
most frequent treatment modality used for the management of residual CBD stones at our hospital. 
Although initial success rate seems low, the fact that endoscopic sphincterotomy is a less invasive 
procedure justifies its preferential utilization. The study does not compare the results of 
endoscopic management with open surgery, as the number of patients managed by open 
choledochotomy is very small. 
Keywords: Common bile dust stones, Retained common bile duct stones, Endoscopic 
sphincterotomy, Endoscopic retrograde cholangiopancreaticography 
INTRODUCTION 
In the era prior to minimally invasive surgery, open 
choledochotomy was the gold standard in the 
management of common bile duct (CBD) stones of 
patients undergoing cholecystectomy for gallstones.1 
The introduction of endoscopic sphincterotomy (ES) 
in 1974 revolutionized the management of CBD 
stones, especially of retained calculi. The technique 
was primarily introduced for retained stones,2 but 
with increasing experience, it has been successfully 
used in 90% to 95% of patients in certain series as a 
primary procedure, without any need for re-
operation.3 Despite such impressive results, a number 
of prospective, randomized trials comparing open 
choledochotomy with pre-operative ES and 
subsequent open cholecystectomy failed to 
demonstrate any significant benefit.2,3 Consequently, 
preoperative ES for choledocholithiasis never became 
a common practice until the introduction of 
laparoscopic techniques.  
The introduction and worldwide acceptance 
of laparoscopic cholecystectomy has revolutionized 
the management of CBD stones. Initially, a 
peroperative cholangiogram (POC) was routinely 
performed during laparoscopic cholecystectomy to 
identify incidental CBD stones, and to delineate the 
biliary anatomy in an attempt to prevent iatrogenic 
biliary injuries;4,5 but most of the recent literature 
supports the use of selective POC due to increase in 
cost, operating time, and false positive or negative 
results associated with the procedure.6 Similarly, 
even when there is a high index of suspicion, a 
routine pre-operative endoscopic retrograde 
cholangio-pancreaticography (ERCP) in patients 
undergoing laparoscopic cholecystectomy, has been 
found to be associated with a significant number of 
negative attempts.7,8  
Consequently, having used all the pre-
operative biochemical and radiological modalities, 
the incidence of residual CBD stones ranges from 2% 
to 10% in different series.9,10 Despite limitations, 
most experts agree that patients with residual CBD 
stones who have previously undergone 
cholecystectomy should be managed by non-
operative techniques and re-exploration reserved for 
selected cases only.11
This study reviews the experience in the 
management of residual CBD stones at the Aga Khan 
University Hospital (AKUH), which is a tertiary care 
teaching hospital in Karachi, Pakistan. Apart from 
open surgery, the options of both endoscopic and 
percutaneous (radiological) management of CBD 
stones are available at this hospital. In the absence of 
a T-tube, our initial approach is to manage these 
patients with endoscopic techniques; and therefore, 
the role of endoscopic sphincterotomy was 
particularly analyzed in our set-up. 
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MATERIAL AND METHODS 
All adult patients diagnosed to have residual CBD 
stones after a previous cholecystectomy, from 
January 1993 to December 2001, were identified 
using ICD-9-CM (International Classification of 
Diseases – 9 – Clinical Modification) coding system 
of diseases. The data was collected from the medical 
records, and the main variables included 
demographic features, presentation, treatment 
modality utilized for each patient, stone clearance, 
procedure related morbidity and mortality, and length 
of hospital stay. The patients who were previously 
managed at other hospitals, and subsequently 
presented to our institution, were excluded from the 
study. 
The ‘stone clearance’ was defined as the 
clearance status of the common bile duct defined in 
the completion cholangiogram after each procedure. 
The number of ancillary procedures required to 
achieve a complete clearance was also considered. 
Morbidity related to both systemic and biliary 
complications of the procedure, and mortality was 
defined as any death occurring within 30 days of the 
procedure. 
As majority of patients in our study were 
managed by ES, it was not possible to compare the 
results of ES with open surgery. The frequencies 
were calculated by using the SPSS (Statistical 
Package for Social Sciences) software package 
(version 11.5) for data analysis.  
RESULTS 
A total of 72 patients presented to AKUH with 
residual CBD stones during the study period. Of 
these, 6 patients were initially managed at other 
hospitals and were excluded from the study. The 
remaining 66 patients constituted the study 
population, and their charts were analyzed in detail. 
The mean age of the patients was 52 years (range: 18 
- 84 years). The majority of patients were females, 
and the female to male ratio was 51:15. The median 
duration of symptoms before diagnosis was 34 
weeks. The mode of presentation includes abdominal 
pain in 34 patients (51.5%), obstructive jaundice in 
15 patients (22.7%), acute cholangitis in 13 patients 
(19.6%), and acute pancreatitis in 4 patients (6%). 
Thirty-four patients (51.5%) were identified 
to have a solitary stone, while the remaining 32 
patients (48.5%) had multiple calculi. The mean size 
of the largest stone was 1.3 centimeters (range: 0.5 to 
3 cms). All the stones were located in the common 
bile duct, except one case where the stone was 
present in the common hepatic duct. 
Five patients were managed by open 
choledochotomy as the primary procedure. The 
reasons for choosing open surgery as a primary 
procedure in these patients included multiple stones 
in 2 patients, and large sized stone (>2 cms) in 3 
patients.  A complete clearance was achieved in all 
the patients at the end of the open procedure with no 
postoperative complications. 
The other 61 patients underwent ES as the 
primary procedure, and the initial clearance was 
achieved in 46 patients (75%). The remaining 15 
patients (25%) had a residual stone and required an 
ancillary procedure to achieve a complete clearance. 
The reasons for failure are shown in Table 1. 
The ancillary procedures consisted of open 
choledochotomy in 9 (15%) patients. The procedure 
was successful in 7 patients, while 2 patients were 
identified to have residual stones on T-tube 
cholangiogram, and were managed by percutaneous 
extraction through the T-tube tract. Six patients 
(10%) were subjected to a repeat ES as an ancillary 
procedure; clearance was achieved in 2 cases after the 
second attempt and in another 2 patients after the 
third attempt. The remaining 2 patients were 
subjected to the extracorporeal shockwave lithotripsy 
(ESWL); it was successful in one patient, while the 
second patient was subjected to open 
choledochotomy to achieve a complete clearance. 
Procedure related complications were 
observed in 17 (28%) patients, as shown in Table 2. 
All the patients were managed conservatively and 
recovered completely. One patient developed wound 
infection, while another had myocardial infarction 
after open choledochotomy as an ancillary procedure. 
There was no procedure related mortality. 
Table-1: Reasons for failure of initial endoscopic 
sphincterotomy in 15 patients 
Reasons for failure Patients (%) 
Large size of the stone 6 (40%) 
Technical difficulty in cannulation 3 (20%) 
Periampullary diverticulum 2 (13%) 
Impacted stone in cystic duct remnant  1 (6%) 
Patient unable to tolerate the procedure 2 (13%) 
Not documented 1 (6%) 
Table-2: Complications of endoscopic 
sphincterotomy in 17 (28%) patients 
Complications Patients (%) 
Mild acute pancreatitis 11 (18%) 
Acute cholangitis 4 (6.5%) 
Hemorrhage from duodenal papilla 2 (3.2%) 
The mean length of hospital stay was 6 days 
(range: 1 to 28 days), and the mean follow up 
duration was 12 months (range: 3 to 38 months). 
Three patients developed recurrent stones in the 
follow up period, and were subjected to a repeat ES. 
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This was successful in one patient, and the other two 
patients ultimately underwent open surgery to 
achieve clearance. 
DISCUSSION 
The incidence of residual CBD stones in different 
series ranges from 2% to 10%;9,10 and despite 
significant advances in endoscopic, percutaneous and 
laproscopic techniques, they continue to present a 
management challenge to the surgeons, 
gastroenterologists and radiologists. There is, 
however, a general consensus that if the gallbladder 
has been removed previously, an endoscopic 
extraction of CBD stones is the preferred approach.11 
We follow the same principle at our hospital and in 
the absence of a T-tube, the first line of management 
for residual stones is endoscopic stone extraction. 
Endoscopic sphincterotomy is a well 
established procedure for treating residual CBD 
stones; and when performed by an expert, ES is 
highly successful and carries a low incidence of 
complications. Schmitt and colleagues12 have 
recently reported a success rate of 100% in the 
removal of retained stones after laparoscopic 
cholecystectomy. More recently, Fiore and co-
workers13 also reported a 100% success rate in 6 
patients in whom the bile duct was not successfully 
cleared laparoscopically. Overall, the rate of 
successful cannulation, and the ability to clear the 
bile duct of stones, ranges from 85% to 92% in 
different series from experienced centers.14 Some of 
these patients with larger stones may also require 
ESWL (extracorporeal shock wave lithotripsy) or 
laser techniques.1 In addition, a small percentage of 
patients who have had a previous Billroth II 
gastrectomy, or when ERCP fails to achieve CBD 
clearance due to technical problems, may require an 
open procedure.15,16
In our series, the initial success rate for ES 
was 75%, and the reasons for failure have already 
been mentioned. This clearance rate is lower when 
compared to results from specialized centers, as 
mentioned above. It might be related to the lack of 
availability of additional sophisticated facilities, like 
mechanical or electrohydraulic lithotripsy and pulsed 
laser techniques, at our hospital at the time of study. 
Other factor might be an overall low volume of 
patients with CBD stones managed at our hospital. A 
few studies from other low volume centers have 
shown similar results. A study from India comparing 
endoscopic versus surgical management of CBD 
stones noted that the clearance rate with ES was 42% 
compared with 93.5% with open choledochotomy.17 
Another non-randomized study comparing ES with 
CBD exploration identified that the success rate with 
an average of 1.5 endoscopic sphincterotomies was 
61% compared with 88% in the open surgery group.18 
A multi-center randomized trial from France also 
revealed a low initial clearance and high morbidity 
when compared with open surgery in patients with an 
intact gallbladder.19
The rate of procedure-related complications 
in our study was also higher as compared to figures 
in international literature.18,20 Despite scrutiny, it was 
difficult to have any plausible explanation, though 
this might also be related to an overall low volume of 
patients with CBD stones managed at our hospital. 
But all the complications were self-limiting, and the 
patients recovered completely without any need for 
surgical intervention; resulting in zero hospital 
mortality.  
This study does not compare the results of 
endoscopic management with open surgery, as the 
number of patients managed by open 
choledochotomy is very small. But, despite 
limitations, this study supports the use of ES in 
patients diagnosed to have common bile duct stones 
after a previous cholecystectomy. Although initial 
success rate is low, the fact that ES is a less invasive 
procedure justifies its preferential utilization. 
However, the patient must be informed that 
successful ES may require multiple visits to the 
endoscopy suite, or an ancillary procedure to achieve 
a complete clearance.  
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